Prognosis of acute symptomatic seizures and impact of prolonged treatment with anti‐seizure medication
Epilepsia · 08.10.2026
DOI: 10.1002/epi.70521 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, online erschienen am 08.10.2026. Verfasst von Hannah Traben und 23 weiteren Autor:innen. Beteiligte Einrichtung: Epilepsy-Center Berlin-Brandenburg, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Acute symptomatic epileptic seizures (ASySs) occur in temporal proximity to acute brain insults. Given their low risk of subsequent unprovoked seizures, current guidelines recommend either no treatment with anti‐seizure medication (ASM) or early discontinuation, yet ASM treatment is often continued beyond hospital discharge. We aimed at investigating the cumulative 3‐year risk and predictors of unprovoked seizures after ASySs and assessing the effect of ASM treatment duration.
Methods
The prospective, multicenter register on the prognosis of acute symptomatic seizures (PROSE register) recruited adults with clinically apparent, acute symptomatic, first‐ever epileptic seizure, excluding status epilepticus. Primary endpoint was occurrence of a first unprovoked seizure. The impact of ASM treatment duration was assessed through a Cox regression correcting for treatment selection bias. The chance of occurrence of a seizure in the next year (COSY) was calculated to evaluate driving eligibility.
Results
The 3‐year cumulative incidence of unprovoked seizures was 14% [95% confidence interval (CI): 7%–21%] among 122 participants with structural etiologies. Male sex (hazard ratio [HR] 9.3; 95% CI 1.9–45.1), early epileptiform electroencephalography (EEG) activity (HR 7.4; 95% CI 1.8–31.1), and latency ≥48 h between onset of underlying condition and ASyS (HR 4.8; 95% CI 1.3–18.1) were independently associated with unprovoked seizures. ASM treatment duration had no apparent effect (HR 1; 95% CI 1–1; p = .84). The initial COSY was 10% and fell below 2% within 2 years. Significance Even in structural etiologies, ASySs bear a relatively low risk of later unprovoked seizures. There is still no evidence favoring prolonged ASM treatments. These findings may help preventing ASM overtreatment and guide counseling on driving eligibility.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Epilepsy-Center Berlin-Brandenburg, Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Department of Neurology, Klinikum Osnabrück, Osnabrück, Germany.
- Department of Neurology, Faculty of Medicine, University of Cologne and University Hospital of Cologne, Cologne, Germany.
- Department and Policlinic of Neurology, Leipzig University Medicine, Leipzig, Germany.
- Department of Neurology, Medical Faculty, Saarland University Medical Center, Homburg, Germany.
- Department of Neurology, Rostock University Medical Center, Rostock, Germany.
ORCID-Profile: Hannah Traben, Julia Herzig-Nichtweiß, Lisa Langenbruch, Felix Kohle, Johann O Pelz, Piergiorgio Lochner, Matthias Wittstock, Albrecht Günther, Angelika Alonso, Marko Blickhan, Silvia Schönenberger, Sascha Berning, Michael P Malter, Annekatrin Müller, Frauke Röll, Kai M Schubert, Marian Galovic, Maximilian Mönch, Martin Holtkamp, Farid Salih, Bernd J Vorderwülbecke
Zitieren
APA
Traben, H., Herzig-Nichtweiß, J., Langenbruch, L., Kohle, F., Pelz, J. O., Lochner, P., Wittstock, M., Günther, A., Alonso, A., Blickhan, M., Schönenberger, S., Berning, S., Malter, M. P., Müller, A., Röll, F., Gubarev, W., Schubert, K. M., Galovic, M., Mönch, M., …, & IGNITE! Study Group (2026). Prognosis of acute symptomatic seizures and impact of prolonged treatment with anti‐seizure medication. Epilepsia. https://doi.org/10.1002/epi.70521
Vancouver
Traben H, Herzig-Nichtweiß J, Langenbruch L, Kohle F, Pelz JO, Lochner P, et al. Prognosis of acute symptomatic seizures and impact of prolonged treatment with anti‐seizure medication. Epilepsia. 2026. doi:10.1002/epi.70521
BibTeX
@article{Traben2026,
author = {Traben, Hannah and Herzig-Nichtweiß, Julia and Langenbruch, Lisa and Kohle, Felix and Pelz, Johann O and Lochner, Piergiorgio and Wittstock, Matthias and Günther, Albrecht and Alonso, Angelika and Blickhan, Marko and Schönenberger, Silvia and Berning, Sascha and Malter, Michael P and Müller, Annekatrin and Röll, Frauke and Gubarev, Waldemar and Schubert, Kai M and Galovic, Marian and Mönch, Maximilian and Grittner, Ulrike and Holtkamp, Martin and Salih, Farid and Vorderwülbecke, Bernd J and IGNITE! Study Group, IGNITE! Study Group},
title = {Prognosis of acute symptomatic seizures and impact of prolonged treatment with anti‐seizure medication},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70521}
}
EUVIMED